deferasirox

The drug is prescribed for the treatment of chronic iron overload in patients with beta-thalassemia or other anemias requiring regular blood transfusions. It is also used in non-transfusion-dependent thalassemia syndromes if deferoxamine therapy is ineffective or contraindicated.

Form: tablets, film-coated

ATC: V03AC03

Manufacturer: Synthon Hispania, S.L. (quality control, batch release)

The drug is prescribed for the treatment of chronic iron overload in patients with beta-thalassemia or other anemias requiring regular blood transfusions. It is also used to treat iron overload in patients with transfusion-independent thalassemia syndromes if deferoxamine therapy is contraindicated or ineffective.

Form: tablets, film-coated

ATC: V03AC03

Manufacturer: Synthon Hispania, S.L. (quality control, batch release)

The drug is prescribed for the treatment of chronic iron overload in patients with beta-thalassemia or other anemias requiring regular blood transfusions. It is also used to treat iron overload in patients with transfusion-independent thalassemia syndromes.

Form: tablets, film-coated

ATC: V03AC03

Manufacturer: Synthon Hispania, S.L. (quality control, batch release)

The drug is used to treat chronic iron overload in patients with beta-thalassemia and other types of anemia requiring regular blood transfusions. It is also used in transfusion-independent thalassemia syndromes if the patient exhibits iron excess.

Form: tablets, dispersible

ATC: V03AC03

Manufacturer: Novartis Pharma Stein AG (full-cycle manufacturing)

The drug is used to treat chronic iron overload in patients with beta-thalassemia (aged 6 years and older) and other anemias requiring regular blood transfusions. It is also used for patients with non-transfusion-dependent thalassemia syndromes if iron overload is detected.

Form: tablets, dispersible

ATC: V03AC03

Manufacturer: Novartis Pharma Stein AG (full-cycle manufacturing)

The drug is used to treat chronic iron overload in patients with beta-thalassemia and other types of anemia that require regular blood transfusions. It is also used in transfusion-independent thalassemia syndromes if deferoxamine therapy is ineffective or contraindicated.

Form: tablets, film-coated

ATC: V03AC03

Manufacturer: Nobel Ilaç Sanai ve Ticaret A.S.

The drug is used to treat chronic iron overload in patients with beta-thalassemia and other forms of anemia requiring regular blood transfusions. It is also used in non-transfusion-dependent thalassemia syndromes if deferoxamine therapy is unsuitable or ineffective.

Form: tablets, film-coated

ATC: V03AC03

Manufacturer: Nobel Ilaç Sanai ve Ticaret A.S.

The drug is used to treat chronic iron overload in patients with beta-thalassemia and other forms of anemia requiring regular blood transfusions. It is also used in transfusion-independent thalassemia syndromes if deferoxamine therapy is contraindicated or ineffective.

Form: tablets, film-coated

ATC: V03AC03

Manufacturer: Nobel Ilaç Sanai ve Ticaret A.S.